The discovery of periodontopathic DPP-4-specific inhibitors and their use in patients with type 2 diabetes mellitus could work in conjunction to lower blood glucose levels since human DPP-4 inhibitors are less effective against bacterial DPP-4 [6]. The gene discussed is DPP4; the disease is diabetes mellitus.